Enovix (NASDAQ:ENVX - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "strong sell" rating to a "sell" rating in a report issued on Saturday, Wall Street Zen reports.
A number of other brokerages also recently commented on ENVX. Canaccord Genuity Group lowered their price objective on Enovix to $2.50 and set a "buy" rating for the company in a research report on Monday, November 16th. Oppenheimer downgraded Enovix from an "outperform" rating to a "market perform" rating in a research report on Friday, November 13th. Cantor Fitzgerald reissued an "overweight" rating and set a $20.00 target price on shares of Enovix in a research report on Thursday, August 13th. Bank of America cut Enovix from a "neutral" rating to an "underperform" rating and cut their price target for the stock from $5.00 to $1.00 in a research note on Wednesday. Finally, William Blair downgraded shares of Enovix from an "outperform" rating to a "market perform" rating in a research note on Monday, August 17th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $6.95.
Read Our Latest Stock Analysis on Enovix
Enovix Trading Down 9.7%
NASDAQ ENVX opened at $1.17 on Friday. The company has a quick ratio of 9.37, a current ratio of 9.10 and a debt-to-equity ratio of 3.05. The stock has a market capitalization of $247.22 million, a P/E ratio of -1.60 and a beta of 2.34. Enovix has a 52-week low of $1.13 and a 52-week high of $9.19. The firm has a 50-day moving average price of $2.11 and a 200 day moving average price of $3.82.
Enovix (NASDAQ:ENVX - Get Free Report) last issued its earnings results on Friday, November 13th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.05. The company had revenue of $11.04 million for the quarter. Enovix had a negative net margin of 406.54% and a negative return on equity of 73.21%. Equities research analysts expect that Enovix will post -0.78 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of ENVX. BlackRock Inc. purchased a new position in Enovix during the 2nd quarter worth approximately $100,054,000. Goldman Sachs Group Inc. raised its stake in Enovix by 22.0% during the 3rd quarter. Goldman Sachs Group Inc. now owns 2,038,868 shares of the company's stock valued at $5,913,000 after purchasing an additional 368,066 shares during the period. Jump Financial LLC lifted its holdings in shares of Enovix by 185.1% in the third quarter. Jump Financial LLC now owns 1,596,042 shares of the company's stock valued at $4,629,000 after purchasing an additional 1,036,189 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Enovix in the second quarter valued at $8,689,000. Finally, Bank of America Corp DE purchased a new stake in shares of Enovix in the second quarter valued at $8,356,000. Institutional investors own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company's batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.